IPRAVENT

This brand name is authorized in Brazil, Canada, Ecuador, Hong Kong, Ireland, Malta, Poland, Romania, United Kingdom

Active ingredients

The drug IPRAVENT contains one active pharmaceutical ingredient (API):

1 Ipratropium UNII J697UZ2A9J - IPRATROPIUM BROMIDE

Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol). Read about Ipratropium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IPRAVENT Pressurised inhalation, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AX03	Ipratropium bromide	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AX Other nasal preparations
Discover more medicines within R01AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 531614060074304
Country: CA	Health Products and Food Branch	Identifier(s): 02246084
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29596-01-11
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 378430
Country: HK	Department of Health Drug Office	Identifier(s): 51066
Country: IE	Health Products Regulatory Authority	Identifier(s): 77507, 77508, 77509, 77510
Country: MT	Medicines Authority	Identifier(s): AA565/70601
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100338517
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65226001